Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Chika Nwachukwu

3PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Mar 30, 2023
Aspirin use is associated with improvement in distant metastases outcome in patients with residual disease after neoadjuvant chemotherapy.

Christopher Johns, Steven K Montalvo, M'Kay Cauble

|Feb 10, 2023
Aspirin Use Is Associated With Improved Outcomes in Inflammatory Breast Cancer Patients.

Christopher Johns, Allen Yen, Asal Rahimi

|Jan 20, 2021
Recurrence risk factors in stage IA grade 1 endometrial cancer.

Chika Nwachukwu, Mana Baskovic, Rie Von Eyben

Pageof 1

Frequent Collaborators

2 joint publications

D W Nathan Kim

2 joint publications

Deborah Farr

2 joint publications

Rachel Wooldridge

2 joint publications

Christopher Johns

2 joint publications

Prasanna G Alluri

2 joint publications

Asal S Rahimi

2 joint publications

Yu-Lun Liu

2 joint publications

Marilyn Leitch

1 joint publications

Rie Von Eyben

1 joint publications

Nisha Unni

Frequent Collaborators

2 joint publications

D W Nathan Kim

2 joint publications

Deborah Farr

2 joint publications

Rachel Wooldridge

2 joint publications

Christopher Johns

Top Related Videos

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on : Jan 18, 2017

12.3K
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on : Sep 12, 2019

8.4K
See more related videos

Top Related Videos

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on : Jan 18, 2017

12.3K
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on : Sep 12, 2019

8.4K
See more related videos